A Sequential Bioequivalence Design with a Potential Ethical Advantage

Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 4

Abstract

The online version of this article (doi:10.1208/s12248-014-9622-7) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Anders Fuglsang

Keywords

Related Articles

Recent progress in the computational prediction of aqueous solubility and absorption

The computational prediction of aqueous solubility and/or human absorption has been the goal of many researchers in recent years. Such anin silico counterpart to the biopharmaceutical classification system (BCS) would ha...

Effect of Ethanol on Opioid Drug Permeability Through Caco-2 Cell Monolayers

Ethanol significantly increased the permeability of oxycodone, oxymorphone and atenolol in a concentration-dependent (1–5%) manner. The permeability of hydromorphone and metoprolol were not altered by ethanol. Th...

Kinetic modeling of plasmid DNA degradation in rat plasma

A major obstacle in gene delivery is the transport of intact plasmid DNA (pDNA) to target sites. We sought to investigate the kinetic processes underlying the degradation of pDNA in a rat plasma model, as this is one of...

Influence of degree of polymerization on behavior of cellulose during homogenization and extrusion/spheronization

The study objective was to investigate the influence of the degree of polymerization (DP) of cellulose materials (microcrystalline cellulose [MCC] and powder cellulose [PC]) on the behavior of these materials during homo...

Download PDF file
  • EP ID EP681707
  • DOI  10.1208/s12248-014-9622-7
  • Views 101
  • Downloads 0

How To Cite

Anders Fuglsang (2014). A Sequential Bioequivalence Design with a Potential Ethical Advantage. The AAPS Journal, 16(4), -. https://europub.co.uk./articles/-A-681707